{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cardiac+Magnetic+Resonance+Scan&page=2", "query": { "intervention": "Cardiac Magnetic Resonance Scan", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cardiac+Magnetic+Resonance+Scan&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T18:40:16.028Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02834650", "title": "Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Muscular Dystrophy, Duchenne" ], "interventions": [ { "name": "Cardiac MRI with contrast", "type": "OTHER" }, { "name": "Cardiac MRI without contrast", "type": "OTHER" }, { "name": "Blood Test", "type": "OTHER" }, { "name": "Heart Rate", "type": "OTHER" }, { "name": "Pulmonary Function Test", "type": "OTHER" }, { "name": "Genetic Testing", "type": "OTHER" }, { "name": "Repeat MRI scan", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": "21 Years", "sex": "MALE", "summary": "7 Years to 21 Years · Male only" }, "enrollment_count": 89, "start_date": "2017-02-01", "completion_date": "2022-03-30", "has_results": false, "last_update_posted_date": "2022-05-10", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 3, "location_summary": "Los Angeles, California • Orange, California • Stanford, California", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02834650" }, { "nct_id": "NCT02744027", "title": "Imaging of Lymphatic Anomalies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gorham Disease", "Lymphatic Diseases", "Lymphangiomatosis" ], "interventions": [ { "name": "Dynamic Contrast Enhanced Magnetic Resonance Lymphangiography (DCMRL)", "type": "OTHER" }, { "name": "Heavy Weighted T2 Imaging (T2W)", "type": "OTHER" }, { "name": "Lymph Node Access", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "2 Years to 80 Years" }, "enrollment_count": 10, "start_date": "2016-04", "completion_date": "2017-12", "has_results": false, "last_update_posted_date": "2018-03-21", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02744027" }, { "nct_id": "NCT06325644", "title": "Well-Formulated Ketogenic Diet Polycystic Kidney Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Polycystic Kidney Disease" ], "interventions": [ { "name": "Ketogenic Diet", "type": "OTHER" }, { "name": "Ketone/Glucose Monitoring", "type": "BIOLOGICAL" }, { "name": "CGM/CKM", "type": "BIOLOGICAL" }, { "name": "Blood Draw", "type": "BIOLOGICAL" }, { "name": "Body Composition", "type": "OTHER" }, { "name": "Change in glomerular filtration rate (mg/mmol) via magnetic resonance imaging (MRI) .", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2024-06-01", "completion_date": "2027-04-01", "has_results": false, "last_update_posted_date": "2026-05-14", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06325644" }, { "nct_id": "NCT05497804", "title": "Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "ISS Stage III Plasma Cell Myeloma", "Multiple Myeloma" ], "interventions": [ { "name": "Bone Marrow Aspiration and Biopsy", "type": "PROCEDURE" }, { "name": "Carfilzomib", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Daratumumab", "type": "BIOLOGICAL" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Chest Radiography", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 17, "start_date": "2022-09-22", "completion_date": "2028-09-04", "has_results": false, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 3, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05497804" }, { "nct_id": "NCT02966665", "title": ": Vascular Function in Health and Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Pulmonary Artery Hypertension", "Heart Failure", "Hypertension" ], "interventions": [ { "name": "Maximum Exercise Tests", "type": "OTHER" }, { "name": "BH4, L-NMMA, Vitamin C, Vitamin E, α-Lipoic Acid and L-Ascorbate", "type": "DRUG" }, { "name": "BQ-123", "type": "DRUG" }, { "name": "Fexofenadine, Ranitidine", "type": "DRUG" }, { "name": "Angiotensin-II, Valsartan", "type": "OTHER" }, { "name": "Acetylcholine, Sodium Nitroprusside, Angiotensin-II, Norepinephrine, Phentolamine", "type": "DRUG" }, { "name": "BQ-123, MitoQ, BH4", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "D. Walter Wray", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 420, "start_date": "2008-09", "completion_date": "2030-08", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02966665" }, { "nct_id": "NCT00573339", "title": "Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy" ], "interventions": [ { "name": "Cardiac MRI", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "35 Years to 65 Years · Female only" }, "enrollment_count": 20, "start_date": "2007-05", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2023-09-01", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00573339" }, { "nct_id": "NCT07042919", "title": "Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Hepatocellular Carcinoma", "Cirrhosis", "Stage III Hepatocellular Carcinoma AJCC v8", "Stage IV Hepatocellular Carcinoma AJCC v8" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Zanzalintinib", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Devalingam Mahalingam", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2026-03-30", "completion_date": "2031-03-04", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07042919" }, { "nct_id": "NCT05775939", "title": "PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Carcinoma", "Esophageal Carcinoma" ], "interventions": [ { "name": "Fludeoxyglucose F-18", "type": "OTHER" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2023-01-20", "completion_date": "2028-07-01", "has_results": false, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05775939" }, { "nct_id": "NCT07823491", "title": "Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Resectable Liposarcoma", "Resectable Soft Tissue Sarcoma", "Resectable Undifferentiated Pleomorphic Sarcoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Intensity-Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Surgical Procedure", "type": "PROCEDURE" }, { "name": "Transthoracic Echocardiography Test", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "RADIATION", "BIOLOGICAL", "OTHER" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 228, "start_date": "2026-12-01", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07823491" }, { "nct_id": "NCT02357082", "title": "Mayo Clinic Cardiac Implantable Electronic Device MRI Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Magnetic Resonance Imaging" ], "interventions": [ { "name": "MRI Scan", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2016-12", "completion_date": "2022-04-20", "has_results": false, "last_update_posted_date": "2022-06-10", "last_synced_at": "2026-09-28T18:40:16.028Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02357082" } ] }